13F HOLDINGS REPORT
Birchview Capital, LP
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0001618205-26-000001
Total Value
$170.8M
Positions
68
Other Managers
0
Confidential Omitted
No
Holdings (68)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KLA CORPORATION | KLAC | 21,883 | $26.6M | 15.57% |
| 2 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 302,842 | $16.3M | 9.56% |
| 3 | COMPASS THERAPEUTICS INC | CMPX | 1,592,938 | $8.6M | 5.01% |
| 4 | STOKE THERAPEUTICS INC | STOK | 260,000 | $8.3M | 4.83% |
| 5 | LAM RESEARCH CORPORATION | LRCX | 40,329 | $6.9M | 4.04% |
| 6 | OLEMA PHARMACEUTICALS INC | OLMA | 269,000 | $6.7M | 3.94% |
| 7 | STRUCTURE THERAPEUTICS INC | GPCR | 90,000 | $6.3M | 3.66% |
| 8 | PROTAGONIST THERAPEUTICS INC | PTGX | 55,000 | $4.8M | 2.81% |
| 9 | ACADIA PHARMACEUTICALS INC | ACAD | 171,000 | $4.6M | 2.67% |
| 10 | OVINTIV INC | OVV | 107,500 | $4.2M | 2.47% |
| 11 | PROTHENA CORP PLC | PRTA | 441,019 | $4.2M | 2.47% |
| 12 | SOLID BIOSCIENCES INC | SLDB | 705,955 | $4.0M | 2.33% |
| 13 | NEUROCRINE BIOSCIENCES INC | NBIX | 27,190 | $3.9M | 2.26% |
| 14 | AMICUS THERAPEUTICS INC | FOLD | 253,000 | $3.6M | 2.11% |
| 15 | BICYCLE THERAPEUTICS PLC | BCYC | 462,700 | $3.3M | 1.92% |
| 16 | PHATHOM PHARMACEUTICALS INC | PHAT | 195,000 | $3.2M | 1.89% |
| 17 | CASTLE BIOSCIENCES INC | CSTL | 80,600 | $3.1M | 1.84% |
| 18 | INTELLIA THERAPEUTICS INC | NTLA | 315,400 | $2.8M | 1.66% |
| 19 | IMMUNOME INC | IMNM | 130,000 | $2.8M | 1.63% |
| 20 | CORCEPT THERAPEUTICS INC | CORT | 67,200 | $2.3M | 1.37% |
| 21 | VERA THERAPEUTICS INC | VERA | 44,000 | $2.2M | 1.30% |
| 22 | QUIDELORTHO CORP | QDEL | 72,548 | $2.1M | 1.21% |
| 23 | NOVOCURE LTD | NVCR | 152,100 | $2.0M | 1.15% |
| 24 | BIODESIX INC | BDSX | 286,804 | $2.0M | 1.14% |
| 25 | CYTOKINETICS INC | CYTK | 30,000 | $1.9M | 1.12% |
| 26 | PHREESIA INC | PHR | 110,700 | $1.9M | 1.10% |
| 27 | EQT CORPORATION | EQT | 34,619 | $1.9M | 1.09% |
| 28 | HARROW HEALTH INC | HROW | 34,000 | $1.7M | 0.98% |
| 29 | TRAVERE THERAPEUTICS INC | TVTX | 43,000 | $1.6M | 0.96% |
| 30 | FOGHORN THERAPEUTICS INC | FHTX | 281,730 | $1.5M | 0.89% |
| 31 | UNITED THERAPEUTICS CORP | UTHR | 3,000 | $1.5M | 0.86% |
| 32 | ULTRAGENYX PHARMACEUTICAL INC | RARE | 62,000 | $1.4M | 0.83% |
| 33 | ALKERMES PLC | ALKS | 50,000 | $1.4M | 0.82% |
| 34 | NEKTAR THERAPEUTICS | NKTR | 31,000 | $1.3M | 0.77% |
| 35 | APOGEE THERAPEUTICS INC | APGE | 16,000 | $1.2M | 0.71% |
| 36 | VERASTEM INC | VSTM | 150,000 | $1.2M | 0.68% |
| 37 | AXSOME THERAPEUTICS INC | AXSM | 6,061 | $1.1M | 0.65% |
| 38 | MASIMO CORP | MASI | 8,280 | $1.1M | 0.63% |
| 39 | 10X GENOMICS INC | TXG | 59,000 | $962,290 | 0.56% |
| 40 | XENON PHARMACEUTICALS INC | XENE | 21,000 | $941,220 | 0.55% |
| 41 | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 69404D108 | 500,000 | $935,000 | 0.55% |
| 42 | KALVISTA PHARMACEUTICALS INC | KALV | 57,000 | $920,550 | 0.54% |
| 43 | FREEPORT-MCMORAN CL-B | FCX | 18,046 | $916,577 | 0.54% |
| 44 | VENTYX BIOSCIENCES INC | 92332V107 | 100,827 | $910,468 | 0.53% |
| 45 | PHARVARIS N V | PHVS | 29,847 | $828,254 | 0.48% |
| 46 | ILLUMINA INC | ILMN | 6,000 | $786,960 | 0.46% |
| 47 | UNIQURE NV | QURE | 30,789 | $736,781 | 0.43% |
| 48 | HALOZYME THERAPEUTICS INC | HALO | 10,100 | $679,730 | 0.40% |
| 49 | BIOHAVEN LTD | BHVN | 59,365 | $670,231 | 0.39% |
| 50 | BRIDGEBIO PHARMA INC | BBIO | 8,688 | $664,545 | 0.39% |
| 51 | TREACE MEDICAL CONCEPTS INC | 89455T109 | 226,947 | $556,020 | 0.33% |
| 52 | PULMONX CORP | LUNG | 250,573 | $553,766 | 0.32% |
| 53 | RAPT THERAPEUTICS INC | 75382E208 | 15,000 | $508,050 | 0.30% |
| 54 | GOSSAMER BIO INC | GOSS | 138,176 | $428,346 | 0.25% |
| 55 | ALPHATEC HOLDINGS INC | ATEC | 18,058 | $379,940 | 0.22% |
| 56 | OUTSET MEDICAL INC | OM | 98,913 | $366,967 | 0.21% |
| 57 | APELLIS PHARMACEUTICALS INC | APLS | 14,000 | $351,680 | 0.21% |
| 58 | LIQUIDIA TECHNOLOGIES INC | LQDA | 10,000 | $344,900 | 0.20% |
| 59 | CANDEL THERAPEUTICS INC | CADL | 60,000 | $339,000 | 0.20% |
| 60 | VOYAGER THERAPEUTICS INC | VYGR | 74,918 | $294,428 | 0.17% |
| 61 | TRINITY CAP INC | TRINZ | 20,000 | $293,000 | 0.17% |
| 62 | INHIBRX BIOSCIENCES INC | INBX | 3,698 | $292,142 | 0.17% |
| 63 | KAYNE ANDERSON BDC INC | KBDC | 20,000 | $286,400 | 0.17% |
| 64 | CULLINAN THERAPEUTICS INC | CGEM | 20,000 | $207,000 | 0.12% |
| 65 | ELUTIA INC | ELUT | 263,018 | $182,193 | 0.11% |
| 66 | ALUMIS INC | ALMS | 10,000 | $97,600 | 0.06% |
| 67 | DOCGO INC | DCGO | 49,908 | $43,809 | 0.03% |
| 68 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 17,000 | $22,950 | 0.01% |